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High -Lactamase Levels Change the Pharmacodynamics of -Lactam
Antibiotics in Pseudomonas aeruginosa Biofilms
Wang Hengzhuang,a Oana Ciofu,b Liang Yang,c,e Hong Wu,a,b,e Zhijun Song,a Antonio Oliver,d Niels Høibya,b,f
Department of Clinical Microbiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmarka; Institute for International Health, Immunology and
Microbiology, University of Copenhagen, Copenhagen, Denmarkb; Department of Systems Biology, Center for Systems Microbiology, Technical University of Denmark,
Lyngby, Denmarkc; Servicio de Microbiología, Hospital Universitario Son Espases, Palma de Mallorca, Spaind; The Singapore Centre on Environmental Life Sciences
Engineering, Nanyang Technological University, Singaporee; European Study Group for Biofilms, European Society of Clinical Microbiology and Infectious Diseases, Basel,
Switzerlandf
Resistance to -lactam antibiotics is a frequent problem in Pseudomonas aeruginosa lung infection of cystic fibrosis (CF) pa-
tients. This resistance is mainly due to the hyperproduction of chromosomally encoded -lactamase and biofilm formation. The
purpose of this study was to investigate the role of -lactamase in the pharmacokinetics (PK) and pharmacodynamics (PD) of
ceftazidime and imipenem on P. aeruginosa biofilms. P. aeruginosa PAO1 and its corresponding -lactamase-overproducing
mutant, PADDh2Dh3, were used in this study. Biofilms of these two strains in flow chambers, microtiter plates, and on alg-
inate beads were treated with different concentrations of ceftazidime and imipenem. The kinetics of antibiotics on the biofilms
was investigated in vitro by time-kill methods. Time-dependent killing of ceftazidime was observed in PAO1 biofilms, but con-
centration-dependent killing activity of ceftazidime was observed for -lactamase-overproducing biofilms of P. aeruginosa in all
three models. Ceftazidime showed time-dependent killing on planktonic PAO1 and PADDh2Dh3. This difference is probably
due to the special distribution and accumulation in the biofilmmatrix of -lactamase, which can hydrolyze the -lactam antibi-
otics. The PK/PD indices of the AUC/MBIC and Cmax/MBIC (AUC is the area under concentration-time curve, MBIC is the mini-
mal biofilm-inhibitory concentration, and Cmax is the maximum concentration of drug in serum) are probably the best parame-
ters to describe the effect of ceftazidime in -lactamase-overproducing P. aeruginosa biofilms. Meanwhile, imipenem showed
time-dependent killing on both PAO1 and PADDh2Dh3 biofilms. An inoculum effect of -lactams was found for both plank-
tonic and biofilm P. aeruginosa cells. The inoculum effect of ceftazidime for the -lactamase-overproducing mutant
PADDh2Dh3 biofilms was more obvious than for PAO1 biofilms, with a requirement of higher antibiotic concentration and a
longer period of treatment.
Development of resistance to -lactam antibiotics in clinicalisolates of Pseudomonas aeruginosa is a common problem in
the treatment of chronic lung infection in patients with cystic
fibrosis (CF) (1, 2). The chronic lung infection in CF patients is
difficult to eradicate because of biofilm formation in the respira-
tory tract (3, 4). Typical and classical theories of pharmacokinetics
and pharmacodynamics (PK/PD) have been mainly discussed for
planktonic microorganisms (5, 6). However, cells in biofilms are
different than planktonic cells with regard to growth rate (7),
genes expressed (8, 9), andmetabolism (10, 11). The role of-lac-
tamase in treatment of biofilm infections is still unclear. The dose
regimens for -lactam antibiotics on P. aeruginosa biofilms have
not been clarified.
Ceftazidime is an important antipseudomonal agent. The de-
velopment of resistance to ceftazidimeonP. aeruginosa growing in
biofilmswas evaluated in vitro and in vivo in a previous study (12).
Resistance to ceftazidime in biofilm-growing P. aeruginosa is re-
lated to the low growth rate of bacterial cells in the deep layers of
the biofilm and to the production of chromosomal -lactamase
(13–15). The kinetics of ceftazidime on -lactamase-overproduc-
ing biofilms has not been studied.
It was previously shown that-lactamase entrapped in the bio-
filmmatrixmight inactivate-lactamantibiotics (16). In previous
studies (17, 18), we determined in vivo and in vitro the PK/PD
parameters of -lactam antibiotics for biofilm treatments, and we
showed that the time-dependent killing of-lactam antibiotics on
planktonically grown cells was changed to a dose-dependent kill-
ing on biofilms. We hypothesized that the entrapped -lactamase
induced by the -lactam treatment might be the cause of changes
in the kinetics of killing of antibiotics in biofilms. In the present
work, we investigated the influence of hyperproduction of -lac-
tamase on the PK/PD parameters by using three different models
of in vitro biofilms.
Time-kill curve approaches provide more meaningful infor-
mation about the interactions between bacteria and antimicrobial
agents (19–21). We evaluated the time-kill curves of ceftazidime
and imipenem on P. aeruginosa growing in biofilms with basal or
stable derepressed production of -lactamase, due to inactivation
of the AmpC regulatory genes AmpDh1, Dh2, and Dh3. The well-
described inoculum effect, representing the requirement of higher
-lactam antibiotic concentrations to inhibit planktonic bacterial
growth as the bacterial concentration increases, is related to the
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production of -lactamase (22). We have also studied the inocu-
lum effect on planktonic and biofilm P. aeruginosa cells treated
with ceftazidime and imipenem by using the time-kill method.
Colistin was used as a control for a completely different mode of
action (on bacterialmembranes) (23) in comparison to-lactams
(on cell wall synthesis), targeting a different subpopulation (the
cores of the biofilm mushrooms) compared to -lactams (the
surfaces of the biofilm mushrooms), another PK/PD parameter
(concentration dependent) for comparison with -lactams (time
dependent).
MATERIALS AND METHODS
Strains, growth conditions, and chemicals.Laboratory strains, including
wild-type P. aeruginosa PAO1 (basal/ceftazidime-induced -lactamase
activity, 7.8 U/1,468 U of nitrocefin hydrolyzed/min/mg of protein) and
its overproducing -lactamase mutant, PADDh2Dh3 (10,934 U/9,413
FIG1 Time-kill curves of planktonic paired strains of PAO1 and-lactamase-
overproducing PADDh2Dh3 exposed to ceftazidime and imipenem. (A) PAO1
exposed toceftazidime, inoculumof5105CFU/ml; (B)PADDh2Dh3exposed
to ceftazidime, inoculum of 5 105 CFU/ml; (C) PAO1 exposed to imipenem,
inoculum of 5 107 CFU/ml; (D) PADDh2Dh3 exposed to imipenem, inocu-
lum of 5 107 CFU/ml. Portions of similar time-kill curves are not shown.
FIG 2 Time-kill curves of alginate bead biofilms of paired strains PAO1 and
-lactamase-overproducing PADDh2Dh3 exposed to ceftazidime and imi-
penem. (A) PAO1 exposed to ceftazidime, inoculum of 5 105 CFU/ml; (B)
PADDh2Dh3 exposed to ceftazidime, inoculum of 5  105 CFU/ml; (C)
PADDh2Dh3 exposed to ceftazidime, inoculumof 107CFU/ml. TheMICs of
ceftazidime were 2 g/ml for PAO1 and 4 g/ml for PADDh2Dh3. (D)
PAO1 exposed to imipenem, inoculumof 5 106CFU/ml; (E) PADDh2Dh3
exposed to imipenem, inoculum of 5 106 CFU/ml. The MICs of imipenem
were 1 g/ml for PAO1 and 0.5 g/ml for PADDh2Dh3. Portions of similar
time-kill curves are not shown.
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U) (24) were used in this study. The levels of -lactamase in PAO1 and
PADDh2Dh3 were detected by using a chromogenic cephalosporin as
previously described (25). The gfp-tagged strains of PAO1-gfp and
PADDh2Dh3-gfp for biofilm cultivation in a flow chamber were con-
structed by insertion of a mini-Tn7-eGFP-Gmr cassette (26). The growth
minimal medium (ABTG medium) for biofilm cultivation in microtiter
plates and on alginate beads consisted of 1 mM MgCl2, 0.1 mM CaCl2,
15.1 mM (NH4)2SO4, 33.7 mM Na2HPO4 · 2H2O, 22 mM KH2PO4, 51
mM NaCl, 0.01 mM FeCl3, 2.5 g/ml thiamine, and 0.5% glucose (27).
ABTG medium was refreshed every 24 h in wells for biofilm cultivation.
Ceftazidime (Sandoz GmbH, Kundl, Austria), colistin (Colimycin; Lun-
beck A/S, Denmark), and imipenem (Tienam, MSD) were pharmaceuti-
cal grade and stored at 4°C. Antibiotics were dissolved in saline and then
diluted with ABTG medium before application.
Standard susceptibility assay. MICs and minimal bactericidal con-
centrations (MBCs) for planktonic bacteria were determined by the mi-
crotiter method (28). The MICs were also detected by Etest (28).
Killing curves for antibiotics on planktonic cells. Planktonic P.
aeruginosa cells in a 0.1-ml volume containing approximately 105,106, or
107 CFU/ml were added into microtiter wells with ABTG medium (18).
Then, 0.1 ml of different concentrations of ceftazidime, imipenem, and
colistin were mixed into different wells, and cultures were shaken and
cultivated at 37°C for 0, 1, 2, 4, 8, 12, and 24 hours. Then, 0.1-ml samples
(3 samples/time point/concentration) fromwells were serially diluted and
cultured on plates for overnight incubation, and CFU counts were deter-
mined for killing curves of antibiotics on planktonic cells of PAO1 and
PADDh2Dh3. Colistin was used as a control antibiotic. This experiment
was performed two times.
Kinetics of ceftazidime, imipenem, and colistin on alginate bead
biofilms. To prepare the biofilm bacteria, planktonic P. aeruginosa cells
were was immobilized on spherical alginate beads, as previously described
(29–31). Different inocula of alginate bead biofilms were stained with
SYTO 9 (32) (see Fig. S2 in the supplemental material). Alginate beads
(105,106, or 107 CFU/ml) were transferred into flat-bottom microtiter
plates containing different concentrations (0 to 8,192 g/ml) of antibiot-
ics in 0.2 ml of ABTG medium per well (antibiotic challenge plates) and
incubated for 0 h, 1 h, 2 h, 4 h, 8 h, 12 h, or 24 h at 37°C. After antibiotic
incubation, the samples (3 samples/time point/concentration) were har-
vested from wells, serially diluted, and then cultured on plates overnight,
and counting of CFU was performed to determine killing curves of anti-
biotics for alginate beads. This experiment was performed two times.
Kinetics of ceftazidime, imipenem, and colistin on microtiter bio-
films. Isolates were passed twice on agar plates after retrieval from80°C
storage and then grown overnight in Luria-Bertani (LB) medium. After
dilution of the cultures to107 CFU/mlwith ABTGmedium, 0.15mlwas
transferred to all except the negative-control wells of a round-bottom
96-well microtiter plate (catalog number 163320; Nunc A/S, Roskilde,
Denmark). Bacterial biofilms were formed on the surfaces of modified
polystyrenemicrotiter plates (the biofilm growth plates), followed by aer-
obic incubation at 37°C for 5 days without shaking. Pilot studies were
performed to optimize the conditions for biofilm cultivation. The devel-
opment from young biofilm to mature biofilm in microtiter wells is
shown in Fig. S1 of the supplemental material. Fresh ABTG medium was
changed very 24 h. Relative humidity (RH) for biofilm cultivation was
above 95%.The crystal violet stainingmethod (33)was employed to check
the biofilm formation on wells. To determine the microtiter, wells were
rinsed three times with sterile water. Then, 0.15 ml ABTG medium was
added into each well. Biofilms on the surface were scratched by a 10-l
blue inoculation loop (Aktiengesellschaft & Co., Numbrecht Germany)
and suspended in the ABTG medium. Biofilms cells were collected from
the wells into a 50-ml plastic tube, mixed by gentle shaking, and diluted to
105, 106, or 107 CFU/ml. Resuspended biofilm cells were stained with
SYTO9 to check biofilm structure (32) (see Fig. S1). Then, 0.1-ml aliquots
of biofilms cells were placed into flat-bottom microtiter plates (catalog
number 269787; Nunc A/S, Roskilde, Denmark) containing antibiotics
FIG 3 Time-kill curves for microtiter plate biofilms in paired strains of PAO1
and -lactamase-overproducing PADDh2Dh3 exposed to ceftazidime (0 to
512 g/ml) or imipenem (0 to 128 g/ml). (A) PADDh2Dh3 exposed
to ceftazidime, inoculum of 5 105 CFU/ml; (B) PADDh2Dh3 exposed to
ceftazidime, inoculum of 5  106 CFU/ml; (C) PADDh2Dh3 exposed to
ceftazidime, inoculum of 5 107 CFU/ml. (D) PAO1 exposed to ceftazidime,
inoculum of 5  105 CFU/ml; (E) PAO1 exposed to imipenem, inoculum of
5 107 CFU/ml; (F) PADDh2Dh3 exposed to imipenem, inoculum of 5
107 CFU/ml. Portions of similar time-kill curves are not shown.
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with 0.1-ml aliquots of 2-fold dilutions in ABTG medium per well (anti-
biotic challenge plates) and cultured for 1 h to 24 h at 37°C, working with
three wells per concentration. Samples (3 samples/time point/concentra-
tion) were collected at different time points. After serial dilution, a 0.1-ml
sample was put into each plate and the cells were cultivated for CFU
counting. Then, the killing curves were determined. This experiment was
performed two times. The surface-detached biofilms of P. aeruginosa cells
are relevant for non-surface-associated biofilms, such as P. aeruginosa
biofilms during chronic infection in CF (34).
Flow chamber biofilm formation and kinetics study of ceftazidime.
P. aeruginosa biofilms were cultivated at 30°C in flow chambers irrigated
with a minimal medium (35) supplemented with 0.3 mM glucose as pre-
viously reported (36). Biofilms were grown in flow chambers with indi-
vidual channel dimensions of 1 by 4 by 40 mm. The flow system was
assembled and prepared as described previously (36). The flow chambers
were inoculated by injecting 350-l aliquots of overnight cultures diluted
to an optical density at 600 nm of 0.001 into each flow channel by using a
small syringe. After inoculation, the flow channels were left without flow
for 1 h, after which medium flow was started with aWatsonMarlow 205S
peristaltic pump. The mean flow velocity in the flow chambers was 0.2
mm s1, corresponding to laminar flow with a Reynolds number of 0.02.
Day 4 biofilms were treated with different concentrations of ceftazidime
for 2 h, 4 h, 8 h, and 24 h. Then,microscopic observations were performed
on aZeiss LSM510 confocal laser scanningmicroscope (CLSM;Carl Zeiss,
Jena, Germany) equipped with an argon laser detector and filter sets for
monitoring of green fluorescent protein (GFP) fluorescence and 0.3 M
propidium iodide (PI). Images were obtained using a 40/1.3 numerical
aperture Plan-Neofluar oil objective lens. Vertical cross-sectional images
were generated using the IMARIS software package (Bitplane AG, Zurich,
Switzerland). CLSM images were analyzed by use of the computer pro-
gram COMSTAT (35). For CLSM, images acquired at six randomly cho-
sen locations were used to analyze biofilm formation of each strain. A
fixed threshold value and connected volume filtration were used for all
image stacks. Rates of living/dead biomass (green channel/red channel)
were used to make the killing curve for ceftazidime on biofilms. This
experiment was performed two times.
FIG 4 Time-kill curves for -lactamase-overproducing PADDh2Dh3 cells
exposed to colistin. (A) Planktonic PADDh2Dh3 exposed to colistin; (B)
alginate bead biofilms of PADDh2Dh3 exposed to colistin; (C) microtiter
plate biofilms of PADDh2Dh3 exposed to colistin. Portions of similar time-
kill curves are not shown.
FIG 5 Images of a flow chamber biofilm exposed to ceftazidime. PAO1 biofilms were treated with different concentrations of ceftazidime (4, 64, or 1,024g/ml)
for 4 to 24 h. (Green, live cells; red, dead cells; yellow, mixture of live and dead cells).
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RESULTS
Killing curves of antibiotics on planktonic cells.The killing pro-
files of ceftazidime and imipenemagainst planktonicP. aeruginosa
PAO1 and-lactamase-overproducing PADDh2Dh3 are shown
in Fig. 1. The bactericidal activities of ceftazidime and imipenem
appeared to be time dependent for both planktonic PAO1 and
PADDh2Dh3 cells. The MBC of ceftazidime for PAO1 was 32
g/ml at the 8-h time point, but for PADDh2Dh3 it was 32
g/ml at the 12-h time point approximately. The killing effect of
ceftazidime correlated with the time of treatment on both plank-
tonic PAO1 and PADDh2Dh3 cells. A correlation was shown
between the killing rate and the treatment time for ceftazidime
and imipenem on both planktonic PAO1 and PADDh2Dh3
cells. Colistin showed concentration-dependent killing on both
planktonic PAO1 (18) and PADDh2Dh3 cells (see Fig. 4A, be-
low).
Killing kinetics of ceftazidime, imipenem, and colistin
against alginate bead biofilms.Killing profiles of ceftazidime and
imipenem for biofilms on alginate beads are shown in Fig. 2. The
bactericidal activity of ceftazidime appeared to be time dependent
for PAO1 on alginate beads but to be concentration dependent for
PADDh2Dh3 on alginate beads. In the inoculum of 5  105
CFU/ml group, a rapid reduction in bacterial burden was seen
within 1 h when PAO1 on alginate beads was exposed to 128
MIC (256g/ml) andwhen PADDh2Dh3 on beads was exposed
to 2,048 MIC (8,192 g/ml) of ceftazidime. The minimal bio-
film eradication concentration (MBEC) of ceftazidime was
achieved after 1 h for PAO1 (128MIC; 256 g/ml) and after 24
h for PADDh2Dh3 (128MIC; 512g/ml). The killing effect of
ceftazidime was found to correlate with the time of treatment on
PAO1 alginate beads (Fig. 2A); however, for PADDh2Dh3 on
alginate beads it was correlated with the concentration of ceftazi-
dime (Fig. 2B and C). Imipenem showed time-dependent killing
for both PAO1 and PADDh2Dh3 on alginate beads (Fig. 2D and
E). The killing rate on alginate beads was related to the time of
treatment with ceftazidime for PAO1, but it was related to the
concentration of antibiotic for PADDh2Dh3. Colistin showed
concentration-dependent killing on alginate bead biofilms of
PADDh2Dh3 (see Fig. 4B).
Killing kinetics of ceftazidime, imipenem, and colistin
against microtiter well biofilms. To confirm the concentration-
dependent killing of ceftazidime, as shownwith PADDh2Dh3 alg-
inate beads previously, the killing profiles of ceftazidime against the
microtiter plate biofilms of P. aeruginosa PADDh2Dh3were deter-
mined (Fig. 3). Overall, the bactericidal activity of ceftazidime ap-
peared to be concentration dependent for microtiter plate biofilm
cells of PADDh2Dh3 (Fig. 3). The MBEC of ceftazidime on
PADDh2Dh3 was 512 g/ml at the 24-h time point for the two
inoculumgroups of 5 105CFU/ml and 5 106CFU/ml (Fig. 3A
and B), but a higher concentration of ceftazidimewas required for
the 5 107 CFU/ml group to eradicate the biofilm cells (Fig. 3C).
The killing effect of ceftazidime was found to correlate with the
concentration of treatment on biofilm PADDh2Dh3 cells and
time-dependent killing on biofilm PAO1 cells, but the killing ef-
fect of imipenem was time dependent on both the PAO1 and
PADDh2Dh3microtiter plate biofilms (Fig. 3). Colistin showed
concentration-dependent killing on both PAO1 (18) and
PADDh2Dh3 microtiter plate biofilms (Fig. 4C). A portion of
the results for imipenem and colistin in microtiter plate biofilms
was reported in a previous study (18).
Flow chamber biofilm formation and killing kinetics of cef-
tazidime. To confirm the previous results that ceftazidime
showed concentration-dependent killing in PADDh2Dh3
grown with alginate beads or in microtiter plate biofilms and to
visualize the effect of ceftazidime on biofilm structure, the killing
effects of ceftazidime on PAO1 and PADDh2Dh3 biofilms in a
flow chamber were determined (Fig. 5 to 8). As the mixture of the
red channel and green channel of fluorescence, the image of the
killing effect was shown by the development of yellow in the im-
ages. The maximum killing effect but not MBEC of ceftazidime
was attained at 24 h, a concentration of 1,024 g/ml for PAO1
biofilms. The killing curve for ceftazidime on PAO1 biofilm is
shown in Fig. 8A. The calculation of biomass is shown as the
live/death ratio, to reflect the survival rate of biofilm cells. A time-
dependent killing effect of ceftazidime was observed in PAO1 bio-
films (Fig. 8A).
The killing effect of ceftazidime on -lactamase-overproduc-
ing biofilms of PADDh2Dh3 is presented in Fig. 6 and 8B. The
FIG 6 Images of a flow chamber biofilm exposed to ceftazidime. PADDh2Dh3 biofilms were treated with different concentrations of ceftazidime (4, 64, or
1,024 g/ml) for 4 to 24 h. (Green, live cells; red, dead cells; yellow, mixture of live and dead cells).
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maximum killing effect of ceftazidime was reached at 24 h at a
concentration of 1,024 g/ml, but the killing effect was shown to
be concentration dependent on biofilms of PADDh2Dh3.
Compared with PAO1 biofilms (Fig. 7A), the killing effect of
ceftazidime at 1,024g/ml was obvious on the tops of mushroom
structures of PADDh2Dh3 biofilms (Fig. 7B). At the 24-h time
point, most biofilms of PAO1 were killed by the concentration of
1,024 g/ml ceftazidime (Fig. 7C), but the bottom biofilms of
PADDh2Dh3 survived (Fig. 7D).
Inoculum effects of ceftazidime, imipenem, and colistin on
planktonic cells and biofilms, as detected by time-kill curve
methods. The MBC (for planktonic cells) and MBEC (for bio-
films) of ceftazidime, imipenem, and colistin for planktonic cells
and alginate bead biofilm cells of P. aeruginosa PAO1 and
PADDh2Dh3 were calculated from the time-kill curves (Table
1). As expected, an inoculum effect was found in planktonic and
biofilm P. aeruginosa. As for the inoculum size of 105 to 107 CFU/
ml, the MBC of ceftazidime showed a 4-fold increase (32 to 128
g/ml) for PAO1 and at least a 16-fold increase (32 to512 g/
ml) for PADDh2Dh3; the inoculum effect of imipenem on
PADDh2Dh3 was a 4-fold increase, lower than that to ceftazi-
dime. TheMBEC of ceftazidime for cells on alginate bead biofilms
was increased 4-fold (256 to 512 g/ml) for PAO1, but for
PADDh2Dh3 it was obviously increased, 16-fold (512 to 8,192
g/ml).
The time requirements of antibiotic treatment to reach the
MBC orMBEC were different for 105 versus 107 CFU/ml inocula,
as shown in Table 1. For ceftazidime (time-dependent killing) on
planktonic PAO1 and PADDh2Dh3 cells, the period required
was 8 h and 12 h, respectively, with a 105 CFU/ml inocula, but the
period increased to 24 h and 24 h, respectively, for the 107
CFU/ml inocula to reach the MBC. The killing effect of ceftazi-
dime (time-dependent killing) on alginate beads with PAO1
showed that the time required to reach the MBEC increased from
1 h (for the 105 CFU/ml inoculum) to 12 h (for the 107 CFU/ml
inoculum).
However, for the concentration-dependent killing of ceftazi-
dime on alginate beads PADDh2Dh3, the inoculum effect was
mainly reflected in the increasing concentration of ceftazidime
required (512 to 8,192 g/ml).
The inoculum effect with colistin treatment (area under the
concentration-time curve [AUC]/MIC dependent [17]) was
FIG 7 Images of a flow chamber biofilm exposed to ceftazidime. PAO1 and PADDh2Dh3 biofilms were treated with 1,024 g/ml ceftazidime for 4 h or 24 h.
(A) PAO1 biofilm treated with ceftazidime for 4 h; (B) PADDh2Dh3 biofilm treated with ceftazidime for 4 h; (C) PAO1 biofilm treated with ceftazidime for 24
h; (D) PADDh2Dh3 biofilm treated with ceftazidime for 24 h. (Green, live cells; red, dead cells; yellow, mixture of live and dead cells).
Pharmacodynamics of -Lactams in P. aeruginosa Bioﬁlm
January 2013 Volume 57 Number 1 aac.asm.org 201
 o
n
 February 4, 2013 by TECH KNO
W
LEDG
E CTR O
F DENM
ARK
http://aac.asm
.org/
D
ow
nloaded from
 
observed as a slight (2-fold) increase in concentration or in the
treatment time for both planktonic and biofilm PAO1 and
PADDh2Dh3 cells.
DISCUSSION
Many studies have shown the time-dependent killing effect of cef-
tazidime on planktonic bacteria (37–39), but there have been no
reports for biofilm-grown organisms. In this study, the killing
curves of ceftazidime and imipenem on biofilm-growing P.
aeruginosa were established in order to evaluate their bactericidal
activities in vitro (Fig. 2, 3, and 8). Compared with planktonic
bacteria, the time-dependent kinetics of ceftazidime killing on
biofilm-grown bacteria of wild-type P. aeruginosa PAO1 were re-
tained. However, for antibiotic treatment of biofilm-growing P.
aeruginosa PAO1, higher doses and longer treatment times with
ceftazidime were required than for planktonic cells (Fig. 1 and 2).
These results showed that both treatment time and concentration
should be considered when treating biofilms. We previously re-
ported that the time exceeding the minimal biofilm inhibitory
concentration (TMBIC) is a better PK/PD parameter than the
time exceeding the MIC for planktonic cells (TMIC) for treat-
ment of biofilm infections with -lactam antibiotics (17).
Few studies have looked into the interaction of -lactamase
and antibiotics in biofilm structures (14). In the present study, the
killing effects of -lactam antibiotics were investigated on bio-
films of a -lactamase-overproducing strain. The -lactamase in
the biofilm matrix can lead to the hydrolysis of the -lactam an-
tibiotics before they reach the bacterial cells (40, 41). The source of
-lactamase in biofilms has been considered to be from a sacrifi-
cial layer of bacteria exposed to an antibiotic, with release of de-
fensive enzymes into the extracellular space (14, 15).
Interestingly, ceftazidime showed time-dependent killing on
planktonic cells but concentration-dependent killing on biofilms
of the -lactamase-overproducing strain (Fig. 1, 2, and 8). For
biofilm infections with the-lactamase-overproducing strain, the
optimized PK/PD parameters for ceftazidime are probably the
AUC/MBIC or the maximum concentration of drug in serum
[Cmax]/MBIC ratio. In contrast, imipenem, which is more stable
to AmpC -lactamase (42), maintained the time-dependent kill-
ing on biofilms of PADDh2Dh3 (Fig. 2 and 3).
Although ceftazidime showed concentration-dependent kill-
ing on-lactamase-overproducing biofilms (Fig. 2, 3, and 8B), the
killingwas slower than the fast killing observed for typical concen-
tration-dependent antibiotics like colistin (Fig. 4). -Lactam an-
tibiotics work mainly by inhibiting cell wall biosynthesis by the
microorganism (43). The -lactam nucleus of the molecule irre-
versibly binds to the penicillin-binding protein (PBP) active sites
(44). This irreversible inhibition of the PBPs prevents the final
cross-linking (transpeptidation) of the nascent peptidoglycan
layer, disrupting cell wall synthesis (44). The basic mechanisms
FIG 8 Time-kill curves of flow chamber biofilms of PAO1 and -lactamase-
overproducing PADDh2Dh3 exposed to different doses ceftazidime. (A)
PAO1 flow chamber biofilm results; (B) PADDh2Dh3 flow chamber biofilm
results.
TABLE 1 MBC, MBEC, and inoculum effect of ceftazidime, imipenem, and colistin for planktonic and alginate bead biofilms of P. aeruginosa
PAO1 and PADDh2Dh3 by the time-kill methoda
Inoculum group
Planktonic cells Biofilm cells on alginate beads
MBC (g/ml) Timeb (h) MBEC (g/ml) Timeb (h)
TZ IM CO TZ IM CO TZ IM CO TZ IM CO
PAO1(CFU/ml)
105 32 8 8 8 8 2 256 512 64 1 12 2
106 32 16 8 12 12 2 512 512 64 8 24 4
107 128 32 16 24 24 4 512 2,048 128 12 24 8
PADDh2Dh3 (CFU/ml)
105 32 8 16 12 8 2 512 256 64 24 12 2
106 128 16 16 24 8 2 2,048 1,024 64 24 24 4
107 512 32 16 24 12 4 8192 1,024 64 12 24 4
a TZ, ceftazidime; IM, imipenem; CO, colistin.
b Required time for antibiotic treatment to reach the MBC or MBEC.
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decide the killing pattern of ceftazidime on planktonic and bio-
film-grown bacteria. However, the effect of -lactamase is differ-
ent in biofilms than on planktonic cells due to the accumulation
of the enzyme in thematrix of biofilms (14). The killing pattern of
-lactam antibiotics is affected by the amount and density of
-lactamase in a biofilm. In previous studies, mathematical mod-
els predicted the rate of accumulation of the enzyme in the poly-
saccharide matrix and showed that high levels of chromosomal
-lactamase growing in biofilms would be exposed to reduced
concentrations of -lactam antibiotics (41, 45).
As shown in this study, the killing pattern of ceftazidime was
changed to concentration-dependent killing for biofilm cells (Fig.
2, 3, and 8B). The concentration of a -lactam is a limiting factor
in the treatment of biofilms, and the pharmacodynamic parame-
ters for these time-dependent killing antibiotics are changed (40).
Our data showed for the first time how the relevant resistance
mechanism of -lactamase changes the PK/PD of antibiotics in
biofilm-grown P. aeruginosa. Because the time-dependent killing
of -lactam antibiotics in planktonic bacteria is changed to con-
centration-dependent killing in biofilms, dose regimens of these
antibiotics probably are changed in biofilm infections. This dis-
covery shows the potentially important clinical consequenceswith
dosing regimens of -lactam antibiotics for biofilm infections.
The inoculum effect has been reported in many studies for
planktonic microorganisms, but we identified very few studies of
the inoculum effect in biofilms. The mechanism of the inoculum
effect for a planktonic population is partly in relation to the quan-
tity of-lactamase (22), but themechanismof the inoculumeffect
for microbial biofilms is still unclear. Other possible reasons for
the inoculum effect in planktonicmicroorganisms include factors
related to quorum sensing (46), decreasing expression of selected
PBPs (47, 48), and expression of autolysins (49). Accumulation
and distribution of -lactamase in biofilm structures are com-
pletely different from those for the planktonic mode (14). As for
the biofilm parameters in Table 1, the inoculum effect is not only
reflected by the increasing concentration of ceftazidime but also
by the requirement for a longer treatment period with ceftazi-
dime. The specific accumulation of the -lactamase in a biofilm
matrix is probably responsible for the resistance to ceftazidime
and can probably be explained as amain reason that the inoculum
effect of ceftazidime for PADDh2Dh3 was more obvious than
with PAO1. This is the first time that the characteristics of the
inoculum effect for antibiotics and biofilm-grown P. aeruginosa
have been studied.
The traditional concept of the inoculum effect focuses on the
changes in concentrations of antibiotics for planktonic microor-
ganisms, but this study showed for the first time that the killing
effect for different inoculum sizes for biofilms required both cor-
responding higher concentrations and longer treatment times
with the antibiotics.
In conclusion, this study has originally established the time-kill
approach in three P. aeruginosa biofilm models for antibiotic ac-
tions in vitro. Ceftazidime showed concentration-dependent kill-
ing on -lactamase-overproducing biofilms of P. aeruginosa in
vitro. This was probably due to the special distribution and accu-
mulation of -lactamase in the biofilm matrix, which can hydro-
lyze -lactam antibiotics. The PK/PD indices of the AUC/MBIC
andCmax/MBIC are proposed to describe the effects of ceftazidime
in biofilm infections with -lactamase-overproducing P. aerugi-
nosa cells. The accumulation of -lactamase in the biofilmmatrix
is amain reason for the inoculumeffect of ceftazidime inP. aerugi-
nosa biofilms. The use of-lactamase inhibitors and-lactamase-
stable compounds in the treatment of biofilms that hyperproduce
a -lactamase are advised.
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